logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11071835 B1

PDFFull Text
Date of Patent:
Jul. 27, 2021

Filed:

Nov. 19, 2014

Inhalable medicaments

Applicant:

Pharmachemie B.v., GA Haarlem, NL;

Inventors:

Erwin Van Achthoven, GA Haarlem, NL;

Johan Keegstra, GA Haarlem, NL;

Michael Imre Goller, GA Haarlem, NL;

Assignee:

PHARMACHEMIE B.V., Haarlem, NL;

Attorney:

BakerHostetler

Primary Examiner:

Valerie L Woodward

Int. Cl.
CPC ...
A61M 15/00 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/58 (2006.01); A61K 31/137 (2006.01); A61K 31/4704 (2006.01); A61K 31/24 (2006.01); A61K 45/06 (2006.01); A61K 31/44 (2006.01); A61K 31/15 (2006.01); A61K 9/14 (2006.01); A61K 31/165 (2006.01);
U.S. Cl.
CPC ...
A61M 15/0008 (2014.02); A61K 9/0075 (2013.01); A61K 9/145 (2013.01); A61K 31/137 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/24 (2013.01); A61K 31/44 (2013.01); A61K 31/4704 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01); A61M 15/009 (2013.01); A61M 15/0021 (2014.02); A61M 15/0028 (2013.01); A61M 15/0078 (2014.02); A61M 15/0086 (2013.01); A61M 15/0091 (2013.01); A61M 15/0026 (2014.02); A61M 2202/064 (2013.01); A61M 2206/16 (2013.01); A61M 2206/20 (2013.01);
Abstract

Described herein is a dry powder inhaler which includes: a reservoir containing a dry powder formulation and an arrangement for delivering a metered dose of the medicament from the reservoir; a cyclone deagglomerator for breaking up agglomerates of the dry powder medicament; a delivery passageway for directing an inhalation-induced air flow through a mouthpiece, the delivery passageway extending to the metered dose of medicament, and an inhalable β2-agonist having a particle size distribution of d10<1 μm, d50=1-3 μm, d90=3.5-6 μm and NLT 99% 10 μm and a lactose carrier.

Find Patent Forward Citations

Loading…